SCHEMBL2296429

SCHEMBL2296429

O=CN1CCCC1c1ccc(Br)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.45
CYP19A1 P11511 2/20 0.41
CYP2C9 P11712 4/20 0.41
CYP2C19 P33261 3/20 0.41
MAPK1 P28482 2/20 0.41
CYP2D6 P10635 1/20 0.41
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
ATM Q13315 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
CHRNA7 P36544 3/20 0.37
CYP3A4 P08684 3/20 0.36
LMNA P02545 1/20 0.36
ALOX15 P16050 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28149189 0.83 TRPA1 (0.53) TSHRCYP2C9CYP2C19MAPK1CYP2D6
SCHEMBL28217526 0.83 SLC18A3 (0.36) CYP19A1ALDH1A1CHRNA7CHRNB2CHRNB4
SCHEMBL13330544 0.82 CHRNB2 (0.55) ALDH1A1CHRNA7LMNACHRNB2CHRNB4
SCHEMBL4158117 0.79 ALDH1A1 (0.42) CYP2C19MAPK1ALDH1A1CHRNA7LMNA
SCHEMBL28148132 0.79 PDE2A (0.40) TSHR
SCHEMBL3785051 0.79 TRPA1 (0.34) ALDH1A1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL6047291 0.78 ESR2 (0.42) LMNA
SCHEMBL27852341 0.78 TRPA1 (0.48) TSHRCYP2C9CYP2C19MAPK1CYP2D6
SCHEMBL1877250 0.78 SLC18A3 (0.44) MAPK1ALDH1A1GAALMNA
SCHEMBL8846952 0.77 CHRNB2 (0.49) CYP2C19CHRNA7CYP3A4CHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106817900-A Novel naphthyridines and isoquinolin and its purposes as CDK8/19 inhibitor 默克专利有限公司 2017-06-09 CN disclosed
US-7999117-B2 Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors ABBVIE INC. 2011-08-16 US disclosed
US-20090186877-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LABORATORIES (US) 2009-07-23 US disclosed
EP-2012780-A4 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LAB (US) 2009-06-24 EP disclosed
EP-2012780-A2 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS Abbott Laboratories (US) 2009-01-14 EP disclosed
WO-2007131016-A2 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LABORATORIES (US) 2007-11-15 WO disclosed
US-20070259937-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LABORATORIES 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259937-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS PARP1, PARP2, PARP4 TSHR 4714/4885CYP19A1 959/4885CYP2C9 1315/4885
US-20090186877-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS PARP1, PARP2, PARP4 TSHR 4714/4885CYP19A1 959/4885CYP2C9 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.